Core Alternative Capital Has $9.37 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Core Alternative Capital trimmed its holdings in shares of Aflac Incorporated (NYSE:AFL) by 13.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 104,877 shares of the financial services provider’s stock after selling 16,910 shares during the period. Aflac makes up about 1.9% of Core Alternative Capital’s holdings, making the stock its 11th biggest position. Core Alternative Capital’s holdings in Aflac were worth $9,367,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of AFL. TD Asset Management Inc lifted its holdings in shares of Aflac by 4.1% during the 4th quarter. TD Asset Management Inc now owns 185,354 shares of the financial services provider’s stock valued at $15,292,000 after buying an additional 7,218 shares during the last quarter. Focus Financial Network Inc. ADV bought a new stake in Aflac in the fourth quarter worth approximately $622,000. J. W. Coons Advisors LLC grew its position in Aflac by 3.1% in the fourth quarter. J. W. Coons Advisors LLC now owns 14,836 shares of the financial services provider’s stock worth $1,224,000 after acquiring an additional 440 shares in the last quarter. Scotia Capital Inc. acquired a new position in shares of Aflac during the 4th quarter worth $470,000. Finally, Bank of Nova Scotia raised its holdings in shares of Aflac by 19.7% during the 4th quarter. Bank of Nova Scotia now owns 75,585 shares of the financial services provider’s stock valued at $6,235,000 after purchasing an additional 12,450 shares in the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Trading Up 0.5 %

Shares of AFL stock opened at $110.59 on Monday. The company has a market capitalization of $62.84 billion, a P/E ratio of 12.21, a P/E/G ratio of 2.60 and a beta of 0.95. Aflac Incorporated has a 12-month low of $74.89 and a 12-month high of $111.14. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The firm has a 50-day moving average price of $104.50 and a 200 day moving average price of $92.98.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, topping the consensus estimate of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.10 billion. During the same period in the previous year, the business earned $1.58 EPS. Aflac’s revenue was down .7% compared to the same quarter last year. Research analysts forecast that Aflac Incorporated will post 6.75 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a $0.50 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.81%. Aflac’s dividend payout ratio (DPR) is presently 22.08%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Morgan Stanley increased their target price on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. UBS Group raised their price objective on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research note on Wednesday, August 14th. Wells Fargo & Company upped their target price on Aflac from $81.00 to $90.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Evercore ISI increased their price target on Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a report on Thursday. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Aflac from $80.00 to $83.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 2nd. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Aflac currently has a consensus rating of “Hold” and a consensus target price of $93.36.

Insider Activity at Aflac

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the sale, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.90% of the stock is currently owned by company insiders.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.